DNA methylation patterns of β-globin cluster in β-thalassemia patients
Authors:
Open Access
- 3 December 2020
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 12 (1) , 1-7
Abstract
Background: Reactivation of fetal hemoglobin (HbF, α2γ2) holds a therapeutic target for β-thalassemia and sickle cell disease. Although many HbF regulators have been identified, the methylation patterns in β-globin cluster driving the fetal-to-adult hemoglobin switch remains to be determined. Results: Here, we evaluated DNA methylation patterns of the β-globin cluster from peripheral bloods of 105 β0/β0 thalassemia patients and 44 normal controls. We also recruited 15 bone marrows and 4 cord blood samples for further evaluation. We identified that the CpG sites in the locus control region (LCR) DNase I hypersensitive site 4 and 3 (HS4-3) regions, and γ- and β-globin promoters displayed hypomethylation in β0/β0-thalassemia patients, especially for the patients with high HbF level, as compared with normal controls. Furthermore, hypomethylations in most of CpG sites of the HS4-3 core regions were also observed in bone marrows (BM) of β0/β0-patients compared with normal controls; and methylation level of γ-globin promoter -50 and + 17 CpG sites showed lower methylation level in patients with high HbF level compared with those with low HbF level and a negative correlation with HbF level among β0-thalassemia patients. Finally, γ-globin promoter + 17 and + 50 CpG sites also displayed significant hypomethylation in cord blood (CB) tissues compared with BM tissues from normal controls. Conclusions: Our findings revealed methylation patterns in β-globin cluster associated with β0 thalassemia disease and γ-globin expression, contributed to understand the epigenetic modification in β0 thalassemia patients and provided candidate targets for the therapies of β-hemoglobinopathies.Keywords
Funding Information
- Guangdong Science and Technology Foundation (2019B030316032)
This publication has 21 references indexed in Scilit:
- A Functional Element Necessary for Fetal Hemoglobin SilencingNew England Journal of Medicine, 2011
- A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expressionBlood, 2011
- KLF1 regulates BCL11A expression and γ- to β-globin gene switchingNature Genetics, 2010
- Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern ChinaClinical Genetics, 2010
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11AScience, 2008
- DNA polymorphisms at the BCL11A , HBS1L-MYB , and β- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell diseaseProceedings of the National Academy of Sciences, 2008
- Developmental- and differentiation-specific patterns of human γ- and β-globin promoter DNA methylationBlood, 2007
- CpG Hypomethylation in a Large Domain Encompassing the Embryonic β-Like Globin Genes in Primitive ErythrocytesMolecular and Cellular Biology, 2007
- Treatment with Azacitidine of Patients with End-Stage β-ThalassemiaNew England Journal of Medicine, 1993
- 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+ThalassemiaNew England Journal of Medicine, 1982